Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background.
Nurphoto | Nurphoto | Getty Images
Shares of Novo Nordisk fell on Monday, after the Danish pharmaceutical giant said its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes drop 15.7% of their weight after 68 weeks.
The company’s stock was down 5.52% at 11:10 a.m. London time.
This breaking news story is being updated.
Welcome to WikipediaNews.com, your premier destination for a diverse range of news categories! Here, we bring you the latest updates and insights from various fields, including technology, culture, science, and more, all inspired by the collaborative spirit of Wikipedia. Whether you're looking for breaking news, in-depth analysis, or trending topics, we’ve got something for everyone. Stay informed and engaged with the ever-evolving world of knowledge!
wikipedianews.com
© Copyright - WikipediaNews.com
